Safety of UVA-riboflavin cross-linking of the cornea
- PMID: 17457183
- DOI: 10.1097/ICO.0b013e3180334f78
Safety of UVA-riboflavin cross-linking of the cornea
Abstract
Purpose: To study potential damage to ocular tissue during corneal collagen cross-linking (X-linking) by means of the riboflavin/UVA (370 nm) approach.
Methods: Comparison of the currently used technique with officially accepted guidelines regarding direct UV damage and the damage created by the induced free radicals (photochemical damage).
Results: The currently used UVA radiant exposure of 5.4 mJ/cm and the corresponding irradiance of 3 mW/cm2 is below the known damage thresholds of UVA for the corneal endothelium, lens, and retina. Regarding the photochemical damage caused by the free radicals, the damage thresholds for keratocytes and endothelial cells are 0.45 and 0.35 mW/cm, respectively. In a 400-microm-thick cornea saturated with riboflavin, the irradiance at the endothelial level was 0.18 mW/cm, which is a factor of 2 smaller than the damage threshold.
Conclusions: After corneal X-linking, the stroma is depopulated of keratocytes approximately 300 microm deep. Repopulation of this area takes up to 6 months. As long as the cornea treated has a minimum thickness of 400 microm (as recommended), the corneal endothelium will not experience damage, nor will deeper structures such as lens and retina. The light source should provide a homogenous irradiance, avoiding hot spots.
Comment in
-
Absorption of UV-light by riboflavin solutions with different concentration.J Refract Surg. 2012 Feb;28(2):91-2. doi: 10.3928/1081597X-20120117-01. J Refract Surg. 2012. PMID: 22313434 No abstract available.
Similar articles
-
Wound healing in the rabbit cornea after corneal collagen cross-linking with riboflavin and UVA.Cornea. 2007 Jun;26(5):600-5. doi: 10.1097/ICO.0b013e318041f073. Cornea. 2007. PMID: 17525659
-
Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus.Cornea. 2010 Apr;29(4):409-11. doi: 10.1097/ICO.0b013e3181bd9f8c. Cornea. 2010. PMID: 20164744
-
Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans.Cornea. 2007 May;26(4):390-7. doi: 10.1097/ICO.0b013e318030df5a. Cornea. 2007. PMID: 17457184
-
[Biophysical principles of collagen cross-linking].Klin Monbl Augenheilkd. 2008 Feb;225(2):131-7. doi: 10.1055/s-2008-1027221. Klin Monbl Augenheilkd. 2008. PMID: 18293264 Review. German.
-
[Therapeutic cross-linking of the cornea using riboflavin/UVA].Klin Monbl Augenheilkd. 2007 Sep;224(9):700-6. doi: 10.1055/s-2007-963492. Klin Monbl Augenheilkd. 2007. PMID: 17846959 Review. German.
Cited by
-
Potential Effects of Corneal Cross-Linking upon the Limbus.Biomed Res Int. 2016;2016:5062064. doi: 10.1155/2016/5062064. Epub 2016 Sep 5. Biomed Res Int. 2016. PMID: 27689081 Free PMC article. Review.
-
Complications of corneal collagen cross-linking.Indian J Ophthalmol. 2022 May;70(5):1466-1474. doi: 10.4103/ijo.IJO_1595_21. Indian J Ophthalmol. 2022. PMID: 35502012 Free PMC article. Review.
-
Efficacy and safety of scleral crosslinking using poly(ethylene glycol)ether tetrasuccinimidyl glutarate for form-deprivation myopia progression in rabbits.RSC Adv. 2021 Sep 27;11(50):31746-31755. doi: 10.1039/d1ra05533j. eCollection 2021 Sep 21. RSC Adv. 2021. PMID: 35496866 Free PMC article.
-
Corneal cross-linking and safety issues.Open Ophthalmol J. 2011 Feb 11;5:14-6. doi: 10.2174/1874364101105010014. Open Ophthalmol J. 2011. PMID: 21399770 Free PMC article.
-
Photoswitchable nanoparticles for in vivo cancer chemotherapy.Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19048-53. doi: 10.1073/pnas.1315336110. Epub 2013 Nov 4. Proc Natl Acad Sci U S A. 2013. PMID: 24191048 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials